LIFE09200604007 Tabish - Homi Bhabha National Institute

Bibliography
76. Fry, R. C.; Svensson, J. P.; Valiathan, C.; Wang, E.; Hogan, B. J.; Bhattacharya, S.; Bugni, J. M.;
Whittaker, C. A.; Samson, L. D., Genomic predictors of interindividual differences in response to
DNA damaging agents. Genes Dev 2008, 22, (19), 2621-6.
77. Machella, N.; Terry, M. B.; Zipprich, J.; Gurvich, I.; Liao, Y.; Senie, R. T.; Kennedy, D. O.;
Santella, R. M., Double-strand breaks repair in lymphoblastoid cell lines from sisters discordant
for breast cancer from the New York site of the BCFR. Carcinogenesis 2008, 29, (7), 1367-72.
78. Zijno, A.; Porcedda, P.; Saini, F.; Allione, A.; Garofalo, B.; Marcon, F.; Guarrera, S.; Turinetto,
V.; Minieri, V.; Funaro, A.; Crebelli, R.; Giachino, C.; Matullo, G., Unsuitability of
lymphoblastoid cell lines as surrogate of cryopreserved isolated lymphocytes for the analysis of
DNA double-strand break repair activity. Mutat Res 2010, 684, (1-2), 98-105.
79. Trenz, K.; Landgraf, J.; Speit, G., Mutagen sensitivity of human lymphoblastoid cells with a
BRCA1 mutation. Breast Cancer Res Treat 2003, 78, (1), 69-79.
80. Trenz, K.; Schutz, P.; Speit, G., Radiosensitivity of lymphoblastoid cell lines with a heterozygous
BRCA1 mutation is not detected by the comet assay and pulsed field gel electrophoresis.
Mutagenesis 2005, 20, (2), 131-7.
81. Baeyens, A.; Thierens, H.; Vandenbulcke, K.; De Ridder, L.; Vral, A., The use of EBVtransformed
cell lines of breast cancer patients to measure chromosomal radiosensitivity.
Mutagenesis 2004, 19, (4), 285-90.
82. Berwick, M.; Vineis, P., Markers of DNA repair and susceptibility to cancer in humans: an
epidemiologic review. J Natl Cancer Inst 2000, 92, (11), 874-97.
83. Cheng, L.; Eicher, S. A.; Guo, Z.; Hong, W. K.; Spitz, M. R.; Wei, Q., Reduced DNA repair
capacity in head and neck cancer patients. Cancer Epidemiol Biomarkers Prev 1998, 7, (6), 465-8.
84. Gorlova, O. Y.; Weng, S. F.; Zhang, Y.; Amos, C. I.; Spitz, M. R.; Wei, Q., DNA repair capacity
and lung cancer risk in never smokers. Cancer Epidemiol Biomarkers Prev 2008, 17, (6), 1322-8.
85. Li, D.; Firozi, P. F.; Chang, P.; Wang, L. E.; Xiong, P.; Sturgis, E. M.; Eicher, S. A.; Spitz, M. R.;
Hong, W. K.; Wei, Q., In vitro BPDE-induced DNA adducts in peripheral lymphocytes as a risk
factor for squamous cell carcinoma of the head and neck. Int J Cancer 2001, 93, (3), 436-40.
86. Spitz, M. R.; Fueger, J. J.; Halabi, S.; Schantz, S. P.; Sample, D.; Hsu, T. C., Mutagen sensitivity
in upper aerodigestive tract cancer: a case-control analysis. Cancer Epidemiol Biomarkers Prev
1993, 2, (4), 329-33.
87. Hsu, T. C.; Johnston, D. A.; Cherry, L. M.; Ramkissoon, D.; Schantz, S. P.; Jessup, J. M.; Winn,
R. J.; Shirley, L.; Furlong, C., Sensitivity to genotoxic effects of bleomycin in humans: possible
relationship to environmental carcinogenesis. Int J Cancer 1989, 43, (3), 403-9.
88. Yu, G. P.; Zhang, Z. F.; Hsu, T. C.; Spitz, M. R.; Schantz, S. P., Family history of cancer,
mutagen sensitivity, and increased risk of head and neck cancer. Cancer Lett 1999, 146, (1), 93-
101.
89. Xiong, P.; Hu, Z.; Li, C.; Wang, L. E.; El-Naggar, A. K.; Sturgis, E. M.; Wei, Q., In vitro
benzo[a]pyrene diol epoxide-induced DNA damage and chromosomal aberrations in primary
lymphocytes, smoking, and risk of squamous cell carcinoma of the head and neck. Int J Cancer
2007, 121, (12), 2735-40.
90. Wu, X.; Gu, J.; Spitz, M. R., Mutagen sensitivity: a genetic predisposition factor for cancer.
Cancer Res 2007, 67, (8), 3493-5.
91. Singh, N. P.; McCoy, M. T.; Tice, R. R.; Schneider, E. L., A simple technique for quantitation of
low levels of DNA damage in individual cells. Exp Cell Res 1988, 175, (1), 184-91.
92. Collins, A. R., The comet assay for DNA damage and repair: principles, applications, and
limitations. Mol Biotechnol 2004, 26, (3), 249-61.
93. Wu, X.; Roth, J. A.; Zhao, H.; Luo, S.; Zheng, Y. L.; Chiang, S.; Spitz, M. R., Cell cycle
checkpoints, DNA damage/repair, and lung cancer risk. Cancer Res 2005, 65, (1), 349-57.
94. Lin, J.; Kadlubar, F. F.; Spitz, M. R.; Zhao, H.; Wu, X., A modified host cell reactivation assay to
measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder
cancer. Cancer Epidemiol Biomarkers Prev 2005, 14, (7), 1832-6.
153